SunHo Received U.S. FDA IND Approval to Initiate Phase I Clinical Trial of IAP0971 as Innovative Immunocytokines.
Release time：2021-12-31 08:54:49
SunHo received the IND approval from FDA to initiate phase I clinical trials of IAP0971. IAP0971 is the first armed PD1-IL15 immunocytokine with IND approval by both FDA and NMPA.